series-a
Stage
1
Investors
About
Neurotrack develops FDA-registered digital tools that provide rapid and clinically validated cognitive screening to detect mild cognitive impairment, dementia, and Alzheimer's disease, integrating with healthcare systems to improve early diagnosis and patient care.
Explore Neurotrack's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.